Skip to main content
2025 WFH Comprehensive Care Summit Main banner

Ilenia Calcaterra, MD, PhD (she/her/hers)

Assistant Professor
Federico II University of Naples, Italy

Ilenia Calcaterra MD PhD is an Associate Professor of Internal Medicine at Federico II University and physician at Federico II University Hospital in the department of Internal Medicine and Haemocoagulation.
Doctorate in “Advanced Biomedical and Surigcal Therapies” (from 2019-2023) University “Federico II” of Naples Cum laude (07/FEB/2023)

Specialization in Internal Medicine (from 2015-2020) University “Federico II” of Naples Vote: 50/50 cum laude (06/MAR/2020)

Master Degree in Medicine and Surgery (from 2007-2013) University of Palermo Vote: 110/110 cum laude (28/OCT/2013)

Ilenia Lorenza Calcaterra is author of 43 full-length papers cited on international journals and 1 preprint with an overall H-index of 16 (listed in section below). Total citations 851 (Scopus). Scopus ID: 56586261800; Web of Science ResearcherID: AAH-6666-2020; ORCID://orcid.org/0000-0001-8077-2809

Member of: Italian Society of Internal Medine (SIMI) as regional councilor; European Society of Atherosclerosis (EAS); Società Italiana per lo studio dell’emostasi e della trombosi (SISET).

Participation in 24 multinational sponsored projects 1 as principal investigator and 23 as sub-investigator of which 1 of Phase 1 (as member of phase 1 unit director Prof. N. Brunetti Pierri).

Expertise in:
- Complex internal patient management and approach to emergency management in an internal environment.
- Management of patients affected by dyslipidaemia (hereditary lipid disorders) and hypertension and management of cardiovascular risk, prevention of atherosclerosis and possible treatment of complications.
- Use and management of innovative and experimental therapies. Diagnosis and treatment of vascular diseases with execution and reporting of arterial and venous vascular ultrasound examinations.
- Management of patients with arterial and venous thrombotic diseases.
- Management of the patient affected by bleeding disorders with reference to haemophilia and the clinical and ultrasound evaluation of joint complications.
- Gene Therapy in Haemophilia
- Clinical Trials conduction.

Disclosure information not submitted.

Presentation(s):